Overview

The Tobramycin Study

Status:
Completed
Trial end date:
2005-03-01
Target enrollment:
Participant gender:
Summary
Evaluate if tobramycin given once a day is at least as efficacious as the traditional tobramycin given three times a day, given with penicillin G, til patients with febrile neutropenia.
Phase:
Phase 4
Details
Lead Sponsor:
Oslo University Hospital
Collaborators:
Sentralsjukehuset i Hedemark
Sentralsjukehuset i Rogaland
Sorlandet Hospital HF
Sykehuset Asker og Baerum
Sykehuset Buskerud
Sykehuset Innlandet HF
The Hospital of Vestfold
The National Institute of Health, Oslo
Ullevaal University Hospital
Treatments:
Tobramycin